SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Universal prescription drug coverage in Canada
16 references·1 citing·44 second hop
Universal prescription drug coverage in Canada (2016)Universal prescription drug coverage in C…Estimated cost of universal public coverage of prescription drugs in Canada (2015)Estimated cost of universal p…The increasing inefficiency of private health insurance in Canada (2014)The increasing inefficiency o…Prescription Drug Insurance Coverage and Patient Health Outcomes: A Systematic Review (2014)Prescription Drug Insurance C…Here today, gone tomorrow: The issue attention cycle and national print media coverage of prescription drug financing in Canada (2013)Here today, gone tomorrow: Th…Universal Drug Coverage and Socioeconomic Disparities in Major Diabetes Outcomes (2012)Universal Drug Coverage and S…Ideas and Politics in Social Science Research (2012)Ideas and Politics in Social …Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010 (2011)Stitching the gaps in the Can…Cost-related prescription nonadherence in the united states and Canada: A system-level comparison using the 2007 international health policy survey in seven countries (2009)Cost-related prescription non…Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Prescription drug cost sharin…Influencing Drug Prices through Formulary-Based Policies: Lessons from New Zealand (2007)Influencing Drug Prices throu…Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma (2006)Impact of two sequential drug…The Common Drug Review: A NICE start for Canada? (2005)The Common Drug Review: A NIC…The Case for a Medicare Drug Coverage Benefit: A Critical Review of the Empirical Evidence (2001)The Case for a Medicare Drug …The Historical Logic of National Health Insurance: Structure and Sequence in the Development of British, Canadian, and U.S. Medical Policy (1998)The Historical Logic of Natio…Going for the Gold: The Redistributive Agenda Behind Market-Based Health Care Reform (1997)Going for the Gold: The Redis…Strained Mercy: The Economics of Canadian Health Care (1985)Strained Mercy: The Economics…Canadian Health Care System: Who Should Pay for All Medically Beneficial Treatments? A Burning Issue (2017)Canadian Health Care System: …THE NORMATIVE ECONOMICS OF HEALTH CARE FINANCE AND PROVISION (1989)The Deteriorating Administrative Efficiency of the U.S. Health Care System (1991)Equity in the finance and delivery of health care : an international perspective (1993)When Money is the Mission — The High Costs of Investor-Owned Care (1999)Health Care Reform: Lessons From Canada (2003)The Affordable Care Act: implications for health-care equity (2017)Agendas, alternatives, and public policies (1984)Agendas, Alternatives, and Public Policies (1985)Increasing Returns, Path Dependence, and the Study of Politics (2000)Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare (2018)The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey (2018)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia (2013)The High Cost of Prescription Drugs in the United States (2016)Canadian Coordinating Office for Health Technology Assessment. (1992)NICE: faster access to modern treatments? Analysis of guidance on health technologies (2001)National Institute for Clinical Excellence and its value judgments (2004)Pharmaceutical Pricing Policies in a Global Market (2008)A Synthesis of Drug Reimbursement Decision-Making Processes in Organisation for Economic Co-operation and Development Countries (2014)Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration (2008)Cochrane Handbook for Systematic Reviews of Interventions (2008)The Oregon Health Insurance Experiment: Evidence from the First Year* (2012)Health for Everyone? (2019)Universal drug coverage and income‐related disparities in glycaemic control (2019)Building on Values: The Future of Health Care in Canada (2005)Health systems financing and the path to universal coverage (2010)Health systems in transition. (2010)Comparison of Canadian public medication insurance plans and the impact on out-of-pocket costs (2017)Universal Pharmacare in Canada: A Prescription for Equity in Healthcare (2019)Medical insurance: A case study of the tradeoff between risk spreading and appropriate incentives (1970)Payment Restrictions for Prescription Drugs under Medicaid (1987)Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes (1991)Income‐Related Differences in the Use of Evidence‐Based Therapies in Older Persons with Diabetes Mellitus in For‐Profit Managed Care (2003)Patient Strategies to Cope with High Prescription Medication Costs: Who is Cutting Back on Necessities, Increasing Debt, or Underusing Medications? (2005)The anticipatory effects of Medicare Part D on drug utilization (2016)Reassessing the concept of policy paradigm: aligning ontology and methodology in policy studies (2013)Conceptualising the politics of social protection expansion in low income countries: The intersection of transnational ideas and domestic politics (2016)When Do Institutions “Bite”? Historical Institutionalism and the Politics of Institutional Change (2016)The doctor as double agent: Information asymmetry, health insurance, and medical care (1991)Health sector reform: Lessons from China (1997)Chapter 2 An overview of the normative economics of the health sector (2000)The New Politics of the Welfare State (2001)The Study of Critical Junctures: Theory, Narrative, and Counterfactuals in Historical Institutionalism (2007)
this work references cited by second hop

References

  • 2007Prescription drug cost sharing: associations with medication and medical utilization and spending and health.875 cited
  • 1998The Historical Logic of National Health Insurance: Structure and Sequence in the Development of British, Canadian, and U.S. Medical Policy340 cited
  • 2012Ideas and Politics in Social Science Research333 cited
  • 1985Strained Mercy: The Economics of Canadian Health Care212 cited
  • 1997Going for the Gold: The Redistributive Agenda Behind Market-Based Health Care Reform155 cited
  • 2011Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010108 cited
  • 2015Estimated cost of universal public coverage of prescription drugs in Canada92 cited
  • 2005The Common Drug Review: A NICE start for Canada?87 cited
  • 2001The Case for a Medicare Drug Coverage Benefit: A Critical Review of the Empirical Evidence84 cited
  • 2014Prescription Drug Insurance Coverage and Patient Health Outcomes: A Systematic Review83 cited
  • 2009Cost-related prescription nonadherence in the united states and Canada: A system-level comparison using the 2007 international health policy survey in seven countries67 cited
  • 2006Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma64 cited
  • 2012Universal Drug Coverage and Socioeconomic Disparities in Major Diabetes Outcomes

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

63 cited
  • 2014The increasing inefficiency of private health insurance in Canada58 cited
  • 2007Influencing Drug Prices through Formulary-Based Policies: Lessons from New Zealand54 cited
  • 2013Here today, gone tomorrow: The issue attention cycle and national print media coverage of prescription drug financing in Canada28 cited
  • Cited by

    • 2017Canadian Health Care System: Who Should Pay for All Medically Beneficial Treatments? A Burning Issue17 cited